Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glu-REST
NCT04145674Phase 2Suspended
- Start
- Oct 2022
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of esmethadone in restless legs syndrome (RLS). Started Oct 2022; status: suspended.
02
Drugs
esmethadone
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT04145674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04145674.